Dexetimide
Showing 1 - 25 of 94
Major Depression Response to Citalopram Therapy in Anorexia
Recruiting
- Anorexia Nervosa
- Citalopram i.v. and p.o
- Citalopram p.o
-
Oggebbio, ItalyIstituto Auxologico Italiano
Mar 21, 2023
MDD Trial in Islamabad (Sertraline, Escitalopram)
Completed
- Major Depressive Disorder
-
Islamabad, PakistanKRL Hospital
Jul 14, 2023
Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)
Not yet recruiting
- Panic Disorder
- Hydroxyzine
- Escitalopram Oxalate
- (no location specified)
Feb 20, 2023
Depressive Disorder, Major Trial in Shanghai (acupuncture, escitalopram, sham-acupuncure)
Not yet recruiting
- Depressive Disorder, Major
- acupuncture
- +3 more
-
Shanghai, Shanghai, China
- +2 more
Jun 5, 2023
Alzheimer, MDD Trial in New York, Orangeburg (Escitalopram Oxalate, Placebo)
Recruiting
- Alzheimer Disease
- Major Depressive Disorder
- Escitalopram Oxalate
- Placebo
-
New York, New York
- +1 more
Dec 29, 2022
Depression, Inflammation Trial in Philadelphia (Escitalopram + Celecoxib, Escitalopram + Placebo)
Active, not recruiting
- Depression
- Inflammation
- Escitalopram + Celecoxib
- Escitalopram + Placebo
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jan 27, 2022
Depression Trial in Fortaleza (Escitalopram 10mg, LABCAT TCJUSS, LABCAT TCJUSS Placebo)
Terminated
- Depression
- Escitalopram 10mg
- +3 more
-
Fortaleza, Ceará, BrazilUnidade de Farmacologia Clínica (UNIFAC - Universidade Federal d
Jun 13, 2022
Outpatients / Inpatients With Depression Trial in Beijing (Escitalopram, Escitalopram+Aripiprazole, Escitalopram+omega-3 PUFAs)
Not yet recruiting
- Outpatients / Inpatients With Depression
- Escitalopram
- +3 more
-
Beijing, Beijing, China
- +2 more
Sep 27, 2022
MDD, Bipolar Disorder, Mixed, Affective; Disorder, Organic Trial in Hangzhou (Escitalopram Oxalate Tablets, Quetiapine Fumarate
Recruiting
- Major Depressive Disorder
- +2 more
- Escitalopram Oxalate Tablets
- Quetiapine Fumarate Tablets
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang University
Aug 9, 2022
MDD Trial in Gwangju (stepwise pharamacotherapy, antidepressant monotherapy group)
Recruiting
- Major Depressive Disorder
- stepwise pharamacotherapy
- antidepressant monotherapy group
-
Gwangju, Korea, Republic ofChonnam National University Hospital
Sep 19, 2023
Tamoxifen in Breast Cancer and in Women at High-Risk of Breast
Active, not recruiting
- Breast Cancer
- +3 more
- citalopram hydrobromide
- +10 more
-
Indianapolis, Indiana
- +3 more
Feb 18, 2022
MDD Trial in Erbil (Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet))
Completed
- Major Depressive Disorder
- Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg
- Citalopram (tablet) 20 mg + Placebo (tablet)
-
Erbil, IraqHawler Psychiatric Hospital and Private Clinic
Mar 16, 2022
MDD Trial in Shanghai (dietary supplement, device, drug)
Recruiting
- Major Depressive Disorder
- Escitalopram+Sulforaphane
- +2 more
-
Shanghai, ChinaShanghai Mental Health Center
Dec 2, 2021
Depression, Parkinson Disease Trial (Nortriptyline, Escitalopram, Placebo)
Recruiting
- Depression
- Parkinson Disease
- Nortriptyline
- +2 more
-
London, United KingdomRoyal Free London NHS Foundation Trust
Nov 2, 2022
Depression Trial in Tulsa (Escitalopram + RT2CK17, Escitalopram + Placebo)
Terminated
- Depression
- Escitalopram + RT2CK17
- Escitalopram + Placebo
-
Tulsa, OklahomaLaureate Institute for Brain Research
Aug 19, 2021
MDD Trial in Canada, United States (PNB01 fixed dose combination of pipamperone and citalopram, Citalopram, Pipamperone)
Completed
- Major Depressive Disorder
- PNB01 fixed dose combination of pipamperone and citalopram
- +2 more
-
Glendale, California
- +30 more
Mar 14, 2022
Stress Urinary Incontinence, Fecal Incontinence Trial in Copenhagen (Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet)
Completed
- Stress Urinary Incontinence
- Fecal Incontinence
- Citalopram 40mg
- +2 more
-
Copenhagen, DenmarkDepartment of Clinical Pharmacology, Bispebjerg and Frederiksber
Jun 8, 2021
MDD Trial in Los Angeles (Brexpiprazole, Placebo, Citalopram Hydrobromide)
Recruiting
- Major Depressive Disorder
- Brexpiprazole
- +8 more
-
Los Angeles, CaliforniaFor additional information regarding sites, contact 844-687-8522
Apr 9, 2021
Mild-to-moderate Depression Trial in China (TECAS Procedure, Escitalopram, Insomnia medication)
Recruiting
- Mild-to-moderate Depression
- TECAS Procedure
- +2 more
-
Shenzhen, Guangdong, China
- +5 more
Nov 24, 2021
MDD Trial in Fort Myers (Auricular Acupuncture, Sham Auricular Acupuncture + Lexapro)
Completed
- Major Depressive Disorder
- Auricular Acupuncture
- Sham Auricular Acupuncture + Lexapro
-
Fort Myers, FloridaCounseling and Psychological Services
Sep 15, 2021
MDD Trial (Escitalopram 20 mg tablet plus Pentoxifylline 400Mg Tablet, Escitalopram 20 mg tablet + Placebo)
Completed
- Major Depressive Disorder
- Escitalopram 20 mg tablet plus Pentoxifylline 400Mg Tablet
- Escitalopram 20 mg tablet + Placebo
- (no location specified)
Jun 13, 2020
MDD Trial (Escitalopram+golimumab, Escitalopram+Calcium Tablet, Escitalopram)
Not yet recruiting
- Major Depressive Disorder
- Escitalopram+golimumab
- +2 more
- (no location specified)
May 10, 2020
Rectal Hypersensitivity, Irritable Bowel Syndrome-Constipation Trial in Augusta, Iowa City (Sensory Adaptation Training,
Completed
- Rectal Hypersensitivity
- Irritable Bowel Syndrome-Constipation
- Sensory Adaptation Training
- Escitalopram Therapy
-
Augusta, Georgia
- +1 more
Aug 4, 2020
OCD, Healthy Individuals Trial in Copenhagen (Escitalopram, Placebo oral tablet)
Recruiting
- Obsessive-Compulsive Disorder/High Compulsive Individuals
- Healthy Individuals
- Escitalopram
- Placebo oral tablet
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Nov 17, 2022
Depression Trial in Atlanta (drug, behavioral, other)
Completed
- Depression
- Selective serotonin re-uptake inhibitor
- +2 more
-
Atlanta, Georgia12 Executive Park Drive, 3rd floor
Oct 13, 2020